Corporate GovernanceApr 16, 2026, 08:12 PM
OraSure appoints John Bertrand, seeks Board declassification
AI Summary
OraSure Technologies announced the appointment of John D. Bertrand as an independent director, a healthcare technology executive with over a decade of experience in AI-enabled diagnostics. Concurrently, the company will seek shareholder approval at its 2026 Annual Meeting to declassify its Board of Directors. These developments stem from a Cooperation Agreement with Altai Capital Management, L.P., under which Altai will withdraw its director nominations for the upcoming Annual Meeting.
Key Highlights
- John D. Bertrand appointed as independent director to OraSure's Board.
- OraSure to seek shareholder approval for Board declassification at 2026 Annual Meeting.
- Company entered Cooperation Agreement with Altai Capital Management.
- Altai Capital will withdraw its director nominations for the Annual Meeting.
- OraSure Board and management to meet regularly with Altai Capital.
Price Impact
More from OSUR